TY - JOUR
T1 - Outcomes with first-versus second-generation drug-eluting stents in coronary chronic total occlusions (CTOs)
T2 - A systematic review and meta-analysis
AU - Lanka, Viswanatha
AU - Patel, Vishal G.
AU - Saeed, Bilal
AU - Kotsia, Anna
AU - Christopoulos, George
AU - Rangan, Bavana V.
AU - Mohammad, Atif
AU - Luna, Michael
AU - Garcia, Santiago
AU - Abdullah, Shuaib M.
AU - Grodin, Jerrold
AU - Hastings, Jeffrey L.
AU - Banerjee, Subhash
AU - Brilakis, Emmanouil S.
PY - 2014/7
Y1 - 2014/7
N2 - OBJECTIVE: The objective of the present study was to perform a systematic review and meta-analysis of studies reporting outcomes after first- and second-generation drug-eluting stent (DES) implantation in chronic total occlusions (CTOs). BACKGROUND: The effect of second- vs first-generation DESs on the outcomes after CTO percutaneous coronary intervention (PCI) has received limited study. METHODS: As of May 2013, thirty-one published studies reported outcomes after DES implantation in CTOs: thirteen uncontrolled studies (3161 patients), three randomized (220 patients) and ten non-randomized (2150 patients) comparative studies with bare-metal stents (BMSs), and two non-randomized (685 patients) and three randomized (489 patients) comparative studies between first- and second-generation DESs. Data from the five studies comparing first with second-generation DESs were pooled using random-effects meta-analysis models. RESULTS: The median and mean duration of follow-up were 12 and 14.4 months, respectively. Compared to first-generation DESs, second-generation DESs were associated with lower incidence of death (odds ratio [OR], 0.37; 95% confidence intervals [CI], 0.15-0.91), target vessel revascularization (OR, 0.59; 95% CI, 0.40-0.87), binary angiographic restenosis (OR, 0.68; 95% CI, 0.46-1.01) and reocclusion (OR, 0.35; 95% CI, 0.17-0.71), but similar incidence of myocardial infarction (OR, 0.45; 95% CI, 0.10-1.95) and stent thrombosis (OR, 0.34; 95% CI, 0.07-1.59). CONCLUSIONS: Compared to first-generation DESs, second-generation DESs are associated with improved angiographic and clinical outcomes in CTO PCI and are the preferred stents for these challenging lesions.
AB - OBJECTIVE: The objective of the present study was to perform a systematic review and meta-analysis of studies reporting outcomes after first- and second-generation drug-eluting stent (DES) implantation in chronic total occlusions (CTOs). BACKGROUND: The effect of second- vs first-generation DESs on the outcomes after CTO percutaneous coronary intervention (PCI) has received limited study. METHODS: As of May 2013, thirty-one published studies reported outcomes after DES implantation in CTOs: thirteen uncontrolled studies (3161 patients), three randomized (220 patients) and ten non-randomized (2150 patients) comparative studies with bare-metal stents (BMSs), and two non-randomized (685 patients) and three randomized (489 patients) comparative studies between first- and second-generation DESs. Data from the five studies comparing first with second-generation DESs were pooled using random-effects meta-analysis models. RESULTS: The median and mean duration of follow-up were 12 and 14.4 months, respectively. Compared to first-generation DESs, second-generation DESs were associated with lower incidence of death (odds ratio [OR], 0.37; 95% confidence intervals [CI], 0.15-0.91), target vessel revascularization (OR, 0.59; 95% CI, 0.40-0.87), binary angiographic restenosis (OR, 0.68; 95% CI, 0.46-1.01) and reocclusion (OR, 0.35; 95% CI, 0.17-0.71), but similar incidence of myocardial infarction (OR, 0.45; 95% CI, 0.10-1.95) and stent thrombosis (OR, 0.34; 95% CI, 0.07-1.59). CONCLUSIONS: Compared to first-generation DESs, second-generation DESs are associated with improved angiographic and clinical outcomes in CTO PCI and are the preferred stents for these challenging lesions.
KW - bare-metal stent
KW - everolimus-eluting stent
KW - paclitaxel-eluting stent
KW - percutaneous coronary intervention
KW - restenosis
KW - sirolimus-eluting stent
KW - zotarolimus-eluting stent
UR - http://www.scopus.com/inward/record.url?scp=84904009049&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84904009049&partnerID=8YFLogxK
M3 - Review article
C2 - 24993986
AN - SCOPUS:84904009049
SN - 1042-3931
VL - 26
SP - 304
EP - 310
JO - Journal of Invasive Cardiology
JF - Journal of Invasive Cardiology
IS - 7
ER -